iMetaMed is a peer-reviewed english-language open-access journal published by Wiley in United States, operating under an open-access model since 2025. The journal covers Medicine (General): Medical technology and Medicine (General): Computer applications to medicine. Medical informatics.
Authors are required to pay an article processing charge to publish in iMetaMed; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, iMetaMed has published 61 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
artificial intelligence, digital health, tumor microenvironment, microbiome, multi-omics, precision medicine
At a glance
- Publisher
- Wiley
- Country
- United States
- Primary language
- English
- License
- CC BY
- Peer review
- Double anonymous peer review
- OA since
- 2025
- Review time
- 21 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- 3066-988X
- electronic
- 3067-364X
Frequently asked questions
Is iMetaMed peer-reviewed?
Does iMetaMed charge an article processing charge (APC)?
What subjects does iMetaMed publish?
What languages does iMetaMed accept?
What is the ISSN of iMetaMed?
3066-988X (print) · 3067-364X (electronic).